Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Botanacor Laboratories was a U.S. third-party analytical testing company focused on hemp and hemp-derived CBD products. Founded in 2014 in Denver, Colorado, the company offered ISO 17025-accredited laboratory services including cannabinoid potency, residual solvents, microbial contamination, terpene analysis, mycotoxins, heavy metals, and related quality and compliance testing. Botanacor built a reputation as a science-first hemp testing lab and was described as an early leader in hemp/CBD testing in North America. In February 2022, Botanacor combined with Agricor Laboratories and SC Laboratories to form a larger national testing network, and in August 2022 the Botanacor brand was rebranded under the SC Labs name. As a result, Botanacor no longer appears to operate as an independent active brand, with its former business folded into SC Labs' commercial testing operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Botanacor Laboratories.